Insulin at 100: still central in protein-based therapy for chronic disease

The discovery of insulin has inspired several pivotal medical and scientific developments during the past 100 years. Here, we describe how insulin as a model protein will drive future advances in peptide- and protein-based therapies for chronic diseases.

Detalles Bibliográficos
Autores principales: Kurtzhals, Peter, von Scholten, Bernt Johan, Kreiner, Frederik Flindt, Gough, Stephen Charles Langford
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Comment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9053185/
https://www.ncbi.nlm.nih.gov/pubmed/35602193
http://dx.doi.org/10.1038/s43856-021-00004-4
_version_ 1784696943484600320
author Kurtzhals, Peter
von Scholten, Bernt Johan
Kreiner, Frederik Flindt
Gough, Stephen Charles Langford
author_facet Kurtzhals, Peter
von Scholten, Bernt Johan
Kreiner, Frederik Flindt
Gough, Stephen Charles Langford
author_sort Kurtzhals, Peter
collection PubMed
description The discovery of insulin has inspired several pivotal medical and scientific developments during the past 100 years. Here, we describe how insulin as a model protein will drive future advances in peptide- and protein-based therapies for chronic diseases.
format Online
Article
Text
id pubmed-9053185
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-90531852022-05-20 Insulin at 100: still central in protein-based therapy for chronic disease Kurtzhals, Peter von Scholten, Bernt Johan Kreiner, Frederik Flindt Gough, Stephen Charles Langford Commun Med (Lond) Comment The discovery of insulin has inspired several pivotal medical and scientific developments during the past 100 years. Here, we describe how insulin as a model protein will drive future advances in peptide- and protein-based therapies for chronic diseases. Nature Publishing Group UK 2021-06-30 /pmc/articles/PMC9053185/ /pubmed/35602193 http://dx.doi.org/10.1038/s43856-021-00004-4 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Comment
Kurtzhals, Peter
von Scholten, Bernt Johan
Kreiner, Frederik Flindt
Gough, Stephen Charles Langford
Insulin at 100: still central in protein-based therapy for chronic disease
title Insulin at 100: still central in protein-based therapy for chronic disease
title_full Insulin at 100: still central in protein-based therapy for chronic disease
title_fullStr Insulin at 100: still central in protein-based therapy for chronic disease
title_full_unstemmed Insulin at 100: still central in protein-based therapy for chronic disease
title_short Insulin at 100: still central in protein-based therapy for chronic disease
title_sort insulin at 100: still central in protein-based therapy for chronic disease
topic Comment
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9053185/
https://www.ncbi.nlm.nih.gov/pubmed/35602193
http://dx.doi.org/10.1038/s43856-021-00004-4
work_keys_str_mv AT kurtzhalspeter insulinat100stillcentralinproteinbasedtherapyforchronicdisease
AT vonscholtenberntjohan insulinat100stillcentralinproteinbasedtherapyforchronicdisease
AT kreinerfrederikflindt insulinat100stillcentralinproteinbasedtherapyforchronicdisease
AT goughstephencharleslangford insulinat100stillcentralinproteinbasedtherapyforchronicdisease

Ejemplares similares